CMO of SYNLAB Suisse moves to AVA LifeScience

CMO of SYNLAB Suisse moves to AVA LifeScience

page1image44068224

PRESS RELEASE 03/02/2020

Former CMO of SYNLAB Suisse moves to AVA LifeScience

AVA LifeScience – the young development company of cutting-edge technologies for precision medicine strengthens the management team. As Chief Medical Officer (CMO), Dr. med. Dr. phil.-nat. Philippe Haas will be responsible for the development of medical strategic concepts and will also build the department of artificial intelligence. The specialist in general internal medicine is also experienced in molecular pathology  (tumor microarrays), and he spent several years as military doctor working on a technology transfer project for the Swiss Army, including the American Special Operations Command.

From 2016 until the end of February 2020, he was CMO of SYNLAB Suisse SA a diagnostics company, part of the largest laboratory service provider in Europe.

page1image38272384

Further Informations:

Download: Press Release

N